You are currently logged into
Cancer Health Directory - My Account or Log Out
Cancer Health Cancer Health
  • Home
  • News
    • News
    • Newsfeed
    • Science News
    • Features
    • Opinions
    • Conferences
    • Slideshows
    • Cancer Health TV
    • By Author
    • RSS Links
  • Cancer Basics
    • Cancer 101
    • Newly Diagnosed
    • Living with Cancer
    • Cancer Treatment
    • Cancer Medications
    • Breast Cancer
    • Colon Cancer
    • Liver Cancer
    • Lung Cancer
    • Prostate Cancer
    • More Types of Cancer
    • Resources
  • Hot Topics
    • Coronavirus (COVID-19)
    • Health Equity
    • Cancer Treatment
    • Car-T Therapy
    • Caregivers
    • Chemotherapy
    • Immunotherapy
    • Marijuana
    • Mental Health
    • Quality of Life
  • Magazine
    • Magazine
    • Current Issue
    • Archives
    • Digital Editions
    • Cancer Health Focus
    • Bulk Subscriptions
    • Email Newsletters
  • Blogs
    • Blogs
    • Recent Posts
    • Browse Bloggers
    • RSS Links
  • Community
    • Cancer Health Stories
    • Cancer Health Forums
    • Ask Cancer Health
    • Polls
    • Surveys
    • Quizzes
    • Calendar
    • Volunteer Jobs
    • Bookstore
    • Amazon Store
  • About Us
    • About Us
    • Masthead
    • Advertise
    • Awards
    • Contact Us
  • Facebook
  • Twitter

© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

© 2021 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Advertisement

Share


Twitter
Facebook
Pinterest
Tumblr
Email

#Darzalex

Tweet
  • Share

Multiple myeloma cells

Injectable Darzalex Combo Delays Multiple Myeloma Progression

The injectable formulation can cut administration time from two or more hours to just five minutes.

Multiple myeloma cells

FDA approves Kyprolis Plus Darzalex Combination for Multiple Myeloma

More than 80% of clinical trial participants experienced complete or partial remission.

Darzalex, Darzalex Faspro

FDA Approves Injectable Formulation of Darzalex for Multiple Myeloma

Darzalex Faspro can be given by subcutaneous injection rather than IV infusion.

FDA Approves Darzalex for Transplant-Eligible Multiple Myeloma

The approval is based on data from CASSIOPEIA, an open-label, randomized, active-controlled phase 3 study.

FDA Approves Darzalex (Daratumumab) for Multiple Myeloma

Darzalex in combination with lenalidomide and dexamethasone is for people who are ineligible for an autologous stem cell transplant.

Darzalex for Multiple Myeloma Can Be Injected Subcutaneously

An advanced study compared intravenous infusions and subcutaneous injections of the antibody treatment.

FDA Approves Darzalex Combo for Newly Diagnosed Multiple Myeloma

Four-drug regimen improves response in people being treated for the first time.

Advertisement

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.